More Information: Refer to this previous announcement and the Utilization Management section of our Provider website. If the drug requested is not associated with an oncology diagnosis, it will be reviewed by BCBSOK. Note: AIM will review requests for oncology drugs that are supported by an oncology diagnosis. Visit the AIM microsite for links to future training dates or register at these links below.ĪIM Medical Oncology Training Dates and Times You can also get a preview of the AIM ProviderPortal and the Medical Oncology program. Join Us for A Webinar to Learn More: It’s important to attend an online training session for more in-depth information. Transparent feedback before transferring to clinical review.Smart clinical algorithms mean real-time determinations, in many cases - Increases payment certainty. ![]() Faster pre-service decision turnaround times than post service reviews.Self-service available 24/7 - Check order status and view order history.Check prior authorization status on the AIM ProviderPortalĪIM’s ProviderPortal Offers End-to-End Efficiencies for pre- and post-service reviews.Post-service review requests should also be submitted directly to AIM via the ProviderPortal.Use the AIM ProviderPortal to request prior authorization (pre-service).If medical records are needed, AIM will request them via the ProviderPortal.Do not submit medical records to BCBSOK for care categories managed by AIM.Tips for using the AIM ProviderPortal for Pre & Post-Service Reviews 11, 2021, AIM Specialty Health ® (AIM), rather than BCBSOK, will manage prior authorization requests and post service medical necessity reviews for drugs in the Pharmacy Medical Oncology care category for some BCBSOK members. What’s Changing: Blue Cross and Blue Shield of Oklahoma (BCBSOK) is changing prior authorization requirements that may apply to some commercial members.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |